ERCC2 and lung cancer: Worldwide, numerous studies investigating the role of TP53 and XPD gene polymorphisms with lung cancer have prompted to inconsistent reports, even though several studies have identified that individuals polymorphic for the tumor suppressor or DNA repair genes are increased the risk for developing lung cancer.